Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients [Phase 2]
Phase 2 open-label study of bavituximab plus pembrolizumab in advanced gastric and gastroesophageal junction cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection [Phase 2]
Phase 2 single-arm pilot studying adjuvant pembrolizumab plus trastuzumab in HER2-positive esophagogastric tumors with persistent circulatin…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases [Phase 2, Phase 3]
Phase 2/3 trial evaluating tislelizumab in combination with SOX for gastric cancer with liver metastases; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing high-dose esomeprazole and amoxicillin dual therapy to bismuth-containing quadruple therapy for Helicobacter pylori-…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication [Phase 4]
A Phase 4 real-world study evaluating quadruple therapy with bismuth colloidal pectin granules for Helicobacter pylori eradication in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating Navicixizumab as monotherapy or in combination in patients with select advanced solid tumors, including colorectal …
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update for afatinib plus paclitaxel as second-line therapy in advanced gastric and gastroesophageal junction cancers.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer [Phase 1]
Phase 1 study investigating bemarituzumab (FPA144) with modified FOLFOX6 in gastric/gastroesophageal cancer has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Chemotherapy Combined With Apatinib and PD-1 Antibody [Phase 2]
Phase 2 trial evaluating chemotherapy combined with apatinib and a PD-1 antibody for gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating camrelizumab in combination with irinotecan or albumin-bound paclitaxel for second-line advanced ga…
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety trial of GEN1029 (HexaBody-DR5/DR5) in malignant solid tumors (termina ted; results posted in 2022).
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial investigating fruquintinib plus irinotecan for advanced gastric cancer is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy [Phase 2, Phase 3]
A clinical trial update on HIPEC combined with gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy is underway (Phase 2/P…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Vactosertib and Durvalumab in Gastric Cancer [Phase 2]
Phase 2 trial update for Vactosertib with Durvalumab in stomach neoplasm (gastric cancer) is ongoing with an unknown status.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: EGFR-targeted Therapy for Gastric Cancer [Phase 2]
Phase 2 trial update of an EGFR-targeted therapy in gastric cancer (adenocarcinoma of the stomach).
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors [Phase 2]
A Phase 2 clinical trial update evaluating [68Ga]Ga-ABY-025 PET for quantifying HER2 status in solid tumors, including esophageal and gastri…
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating disitamab vedotin combined with sintilimab and S-1 for HER2-overexpressing gastric cancer.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial [Phase 2]
Phase 2 trial update on neoadjuvant immunotherapy combined with chemotherapy for locally advanced esophagogastric junction and gastric cance…
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes [Phase 3]
Phase 3 clinical trial evaluating immunotype-based neoadjuvant treatment efficacy in locally advanced gastric cancer; status not yet recruit…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes [Phase 1, Phase 2]
Exploratory Phase Ib/II trial evaluating first-line treatment for unresectable locally advanced/advanced gastric or gastroesophageal junctio…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. [Phase 2]
A Phase 2 biomarker study evaluating the predictive value of biomarkers for the efficacy of neoadjuvant sintilimab plus SOX in gastric adeno…
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects [Phase 1]
Phase 1 trial of active immunotherapy OBI-833 (Globo H-CRM197) in metastatic gastric, breast, colorectal, and lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial evaluating carrelizumab (PD-1) with chemotherapy as neoadjuvant treatment for locally advanced gastric cancer; status not prov…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. [Phase 2]
Phase 2 trial update of a PD-1 antibody in patients with EBV-positive metastatic gastric cancer (Stage IV).